Risk of side effects associated with the use of nevirapine in treatment-naïve patients, with respect to gender and CD4 cell count

HIV Medicine
H KnobelA González

Abstract

A warning about the use of nevirapine (NVP) by its pharmaceutical manufacturer has been issued in which it has been recommended that NVP should not be prescribed in patients with increased risk of toxicity based on CD4 cut-offs and gender. The aim of this study was to determine whether these recommendations are of use in preventing side effects. This retrospective study included antiretroviral drug-naïve patients who started treatment with NVP. Patients were divided into two groups: those with high CD4 counts (H; women: CD4 count >250 cells/microL; men: CD4 count >400 cells/microL) and those with low CD4 counts (L; women: CD4 count <250 cells/microL; men: CD4 count <400 cells/microL). A total of 142 patients were included in the study, 61 in the H group and 81 in the L group. Skin rash developed in 6.56% of patients [95% confidence interval (CI) 2.67-15.70%] in the H group and in 14.81% of patients (95% CI 8.72-24.17%) in the L group (P=0.18). Hepatotoxicity developed in 4.92% (95% CI 1.79-13.50%) and 6.17% (95% CI 2.73-13.66%) of patients with high and low CD4 cell counts, respectively (P=1.0). The recommendations not to use NVP in drug-naïve patients at increased risk of toxicity on the basis of gender and CD4 cell count do n...Continue Reading

References

Dec 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S J Bersoff-MatchaL M Mundy
Nov 17, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K H WongS S Lee
Feb 5, 2002·Expert Opinion on Pharmacotherapy·D Podzamczer, E Fumero
Oct 18, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jerry O SternDouglas L Mayers
Jan 15, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Shilpa M PatelCharles Bennett
Mar 17, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Melisse Sloas Baylor, Rosemary Johann-Liang
Sep 24, 2004·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Hernando KnobelUNKNOWN Grupo Estudio Syndrome Immunodeficiencies Adquirida 26/02 Study Group
Dec 15, 2004·Enfermedades infecciosas y microbiología clínica·José Antonio IribarrenUNKNOWN Consejo Asesor Clínico del Plan Nacional sobre el Sida del Ministerio de Sanidad y Consumo
Apr 21, 2006·AIDS Research and Human Retroviruses·Anna BonjochBonaventura Clotet
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Scott M HammerUNKNOWN International AIDS Society-USA panel

❮ Previous
Next ❯

Citations

Jun 18, 2009·AIDS·Birgit GrundUNKNOWN INSIGHT SMART Body Composition Substudy Group
Feb 4, 2012·AIDS·Betty J DongUNKNOWN AIDS Clinical Trials Group Study 5208 Team
May 23, 2009·HIV Medicine·Manuela ColafigliA De Luca
May 20, 2011·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Sarita D Boyd
May 10, 2012·Drug, Healthcare and Patient Safety·Omary Mashiku MinziGodeliver A Kagashe
Feb 18, 2016·Journal of Pharmaceutical Policy and Practice·Francis KalemeeraJohannes Gaeseb
Jun 5, 2013·Expert Opinion on Drug Safety·Jose V Fernandez-MonteroVicente Soriano
Jun 16, 2015·Japanese Journal of Infectious Diseases·Kashifullah KhanAli Akhtar
Dec 3, 2014·Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi·Chih-Chen ChouSusan Shin-Jung Lee
Jan 15, 2010·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Shicheng GaoYupin Rong
Apr 17, 2012·International Journal of Hepatology·Manuela G NeumanCharles Parry
Nov 3, 2016·Pharmacoepidemiology and Drug Safety·Annemie StewartKaren Cohen
Mar 31, 2017·AIDS·Christine KatlamaRobert L Murphy
Oct 7, 2010·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Edgardo Gabriel BottaroLidia Isabel Cassetti
Apr 9, 2019·Global Social Welfare : Research, Policy & Practice·Jane Kato-WallaceElizabeth Miller
Jun 25, 2009·Pharmacoepidemiology and Drug Safety·Hossein KhaliliFarahnaz Almasi
Dec 17, 2019·The Journal of the Association of Nurses in AIDS Care : JANAC·Greer A RaggioChristina Psaros
Mar 14, 2009·Current Opinion in Infectious Diseases·Caroline A Sabin, Andrew N Phillips

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.